Collaboration, partnership, and clinical integration are key.
The ongoing Oxford GPS PROTECT study encompasses over 1,500 patients and aims to provide "the highest level of evidence in ...
NINGBO, ZHEJIANG, CHINA, February 3, 2026 /EINPresswire.com/ -- Ningbo Qinmeng Maternal and Child Products Co., Ltd., a ...
K grant awarded to internationally ranked top-10 cancer institute supports expansion of MeCo Diagnostics’ predictive biomarker guiding antifibrotic therapy SAN DIEGO, CA, UNITED STATES, February 26, ...
Integrating "Physical Intelligence" to Accelerate Next-Gen Drug Validation and Bio-AX Revolution SANTA CLARA, CA, ...
AI algorithms have demonstrated a sensitivity of approximately 91% in detecting early dental caries, compared to 84% for ...
Healthcare Asia Magazine on MSN
Software, precision devices drive Australia’s diagnostic imaging growth
Australia held 4% of the APAC diagnostic imaging market in 2025. Australia’s diagnostic imaging market is set to grow at ...
Epredia will add Mindpeak AI modules for pathology to its digital pathology portfolio, offering enhanced precision and speed in diagnostic image review Epredia, a global leader in precision cancer ...
The Mehta Research Group leverages new technologies to improve individualized nutrition strategies and prevent disease.
SHENZHEN CITY, GUANGDONG PROVINCE, CHINA, February 9, 2026 /EINPresswire.com/ -- The global insert molding industry has ...
The partnership will accelerate nationwide access to the EPISEEK® Multi-Cancer Early Detection Test Adding the ...
Shifting the focus from organ to biomarker has unlocked new options for rare and advanced cancers. Uneven efficacy, diagnostic access, and regulation still slow clinical rollout.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results